{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:24:50Z","timestamp":1764433490240},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This exploratory analysis investigates the prevalence and risk factors of neurocognitive toxicity in postpartum women on HIV treatment in response to a concern of an Isoniazid Preventive Therapy (IPT)\/Efavirenz interaction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Design<\/jats:title>\n                <jats:p>Pregnant women on HIV treatment from countries with high TB prevalence were randomized in IMPAACT P1078 to 28\u00a0weeks of IPT started either during pregnancy or at 12\u00a0weeks postpartum. Partway through study implementation, the Patient Health Questionnaire 9, the cognitive complaint questionnaire, and the Pittsburg Sleep Quality Index were added to evaluate depression, cognitive function, and sleep quality at postpartum weeks. Screening for peripheral neuropathy was conducted throughout the study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We summarized percentages of women with depression symptoms, cognitive dysfunction, poor sleep quality and peripheral neuropathy and assessed the association of 11 baseline risk factors of neurotoxicity using logistic regression, adjusted for gestational age stratum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 956 women enrolled, 749 (78%) had at least one neurocognitive evaluation. During the postpartum period, the percentage of women reporting at least mild depression symptoms, cognitive complaint and poor sleep quality peaked at 13%, 8% and 10%, respectively, at 12\u00a0weeks, and the percentage of women reporting peripheral neuropathy peaked at 13% at 24\u00a0weeks. There was no evidence of study arm differences in odds of all four neurotoxic symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Timing of IPT initiation and EFV use were not associated with symptoms of neurotoxicity. Further study is advised to formally assess risk factors of neurotoxicity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05341-3","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T09:03:22Z","timestamp":1673946202000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Patricia","family":"Mandima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Baltrusaitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Montepiedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Mathad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyne","family":"Onyango-Makumbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandisa","family":"Nyati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ngocho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gift","family":"Chareka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ponego","family":"Ponatshego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaerolwe","family":"Masheto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Jean-Philippe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Stranix-Chibanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the IMPAACT P1078 T. B. APPRISE study team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon","family":"Saloojee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"El-Sadr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Faith","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucky","family":"Mokgatlhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Munderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome Amir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Kwagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alwyn","family":"Mwinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Papa Salif","family":"Sow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerrold J.","family":"Ellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"John-Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enid","family":"Kabugho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deo","family":"Wabwire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen","family":"Kaganzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Maena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajira","family":"Kataike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmie","family":"Marote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercy","family":"Mutambanengwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teacler","family":"Nematadzira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzen","family":"Maonera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vongai","family":"Chanaiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapiwa","family":"Mbengeranwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukunena","family":"Maturure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsungai","family":"Mhembere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasreen","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haseena","family":"Cassim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Mathiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Coetzee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Louw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlize","family":"Smuts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindie","family":"Rossouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdel","family":"Rossouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"de Vaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Mbaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"du Preez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieda","family":"Verheye-Dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisa","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boniface","family":"Njau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philoteus","family":"Sakasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seleman","family":"Semvua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tebogo J.","family":"Kakhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuto","family":"Ralegoreng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayotunde","family":"Omoz-Oarhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unoda","family":"Chakalisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishi","family":"Suryavanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandesh","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neetal","family":"Nevrekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuanglada","family":"Tongprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavitiya","family":"Sudjaritruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chintana","family":"Khamrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prapaporn","family":"Janjing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Flore","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Linda","family":"Aristhomene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Lespinasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emelyne","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy James","family":"Loftis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camlin","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Rexroad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Browning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"unstructured":"WHO consolidated guidelines on tuberculosis: Module 1: Prevention: Tuberculosis preventive treatment.Available at:https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331170\/9789240001503-eng.pdf. Accessed December 14, 2021","key":"5341_CR1"},{"issue":"8","key":"5341_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2165\/11534340-000000000-00000","volume":"24","author":"JS Kass","year":"2010","unstructured":"Kass JS, Shandera WX. Nervous system effects of antituberculosis therapy. CNS Drugs. 2010;24(8):655\u201367.","journal-title":"CNS Drugs"},{"key":"5341_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1124\/pr.117.013706","volume":"70","author":"DA Dalwadi","year":"2018","unstructured":"Dalwadi DA, Ozuna L, Harvey BH, Viljoen M, Schetz JA. Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs. Pharmacol Rev. 2018;70:684\u2013711.","journal-title":"Pharmacol Rev"},{"key":"5341_CR4","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1111\/bcp.13600","volume":"84","author":"D Atwine","year":"2018","unstructured":"Atwine D, Bonnet M, Taburet AM. Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review. Br J Clin Pharmacol. 2018;84:1641\u201358.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"5341_CR5","doi-asserted-by":"publisher","first-page":"e01841","DOI":"10.1128\/AAC.01841-16","volume":"61","author":"P Curley","year":"2017","unstructured":"Curley P, Rajoli RKR, Moss DM, Liptrott N, Letendre S, Owen A, et al. Efavirenz is predicted to accumulate in brain tissue: An in silico, in vitro, and in vivo investigation. Antimicrob Agents Chemother. 2017;61(1):e01841\u2013e1916. https:\/\/doi.org\/10.1128\/AAC.01841-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"5341_CR6","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1128\/AAC.02532-14","volume":"58","author":"MH Court","year":"2014","unstructured":"Court MH, Almutairi FE, Greenbalt DJ, Hazarika S, Sheng H, Klein K, et al. Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6. Antimicrob Agents Chemother. 2014;58:4145\u201352.","journal-title":"Antimicrob Agents Chemother"},{"issue":"109","key":"5341_CR7","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/cpt.2044","volume":"2021","author":"K Gausi","year":"2021","unstructured":"Gausi K, Wiesner L, Norman J, Wallis C, Onyango-Makumbi C, Chipato T, et al. Pharmacokinetics and drug-drug Interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: Importance of genotyping. Clin Pharmacol Ther. 2021;2021(109):1034\u201344.","journal-title":"Clin Pharmacol Ther"},{"key":"5341_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-016-0892-8","volume":"16","author":"T Azale","year":"2016","unstructured":"Azale T, Fekadu A, Hanlon C. Treatment gap and help-seeking for postpartum depression in a rural African setting. BMC Psychiatry. 2016;16:1\u201310.","journal-title":"BMC Psychiatry"},{"key":"5341_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yhbeh.2015.08.008","volume":"77","author":"S Brummelte","year":"2016","unstructured":"Brummelte S, Galea LAM. Postpartum depression: Etiology, treatment and consequences for maternal care. Hormones and Behaviour. 2016;77:153\u201366.","journal-title":"Hormones and Behaviour"},{"unstructured":"WHO recommends dolutegravir as preferred HIV treatment option in all populations, July 22, 2019. Available at: https:\/\/www.who.int\/news\/item\/22-07-2019-who-recommends-dolutegravir-as-preferred-hiv-treatment-option-in-all-populations. Accessed May 25, 2021","key":"5341_CR10"},{"key":"5341_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa1813060","volume":"381","author":"A Gupta","year":"2019","unstructured":"Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, et al. Isoniazid Preventive Therapy in HIV-infected pregnant and postpartum women. N Engl J Med. 2019;381:1333\u201346.","journal-title":"N Engl J Med"},{"key":"5341_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"5341_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","volume":"24","author":"S Simioni","year":"2010","unstructured":"Simioni S, Cavassini M, Annoni JM, Abraham AR, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24:1243\u201350.","journal-title":"AIDS"},{"key":"5341_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"5341_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4269\/ajtmh.2010.09-0629","volume":"83","author":"S Mehta","year":"2010","unstructured":"Mehta S, Ahmed A, Kariuki BW, Said S, Omasete F, Mendillo M, et al. Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya. Am J Trop Med Hyg. 2010;83:565\u201370.","journal-title":"Am J Trop Med Hyg"},{"unstructured":"Botha MN. Validation of the Patient Health Questionnaire (PHQ\u20139) in an African context. 2011. https:\/\/repository.nwu.ac.za\/handle\/10394\/4647","key":"5341_CR16"},{"key":"5341_CR17","first-page":"1245","volume":"25","author":"D Akena","year":"2013","unstructured":"Akena D, Joska J, Obuku EA, Stein D. Sensitivity and specificity of clinician administered screening instruments in detecting depression among HIV-positive individuals in Uganda. AIDS Care Psychological and Socio-Medical Aspects of AIDS\/HIV. 2013;25:1245\u201352.","journal-title":"AIDS Care Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"issue":"3","key":"5341_CR18","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1503\/cmaj.110829","volume":"184","author":"L Manea","year":"2012","unstructured":"Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. CMAJ. 2012;184(3):E191\u20136. https:\/\/doi.org\/10.1503\/cmaj.110829.","journal-title":"CMAJ"},{"key":"5341_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0163278716678906","volume":"41","author":"MB Popevi\u0107","year":"2018","unstructured":"Popevi\u0107 MB, Milovanovic APS, Milovanovic S, Nagorni-Obradovi\u0107 L, Ne\u0161i\u0107 D, Velaga M. Reliability and validity of the Pittsburgh Sleep Quality Index-Serbian translation. Eval Health Prof. 2018;41:67\u201381.","journal-title":"Eval Health Prof"},{"unstructured":"Division of AIDS (DAIDS). Table for Grading the Severity of Adult and Pediatric Adverse Events, Corrected Version 2.1. 2017. Available at: Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events (nih.gov). Accessed December 14, 2021","key":"5341_CR20"},{"key":"5341_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12884-020-02887-y","volume":"20","author":"M Kaiyo-Utete","year":"2020","unstructured":"Kaiyo-Utete M, Dambi JM, Chingono A, Mazhandu FSM, Madziro-Ruwizhu TB, Henderson C, et al. Antenatal depression: an examination of prevalence and its associated factors among pregnant women attending Harare polyclinics. BMC Pregnancy Childbirth. 2020;20:197\u2013197.","journal-title":"BMC Pregnancy Childbirth"},{"doi-asserted-by":"publisher","unstructured":"Ngocho JS, Watt MH, Minja L, Knettel BA, Mmbaga BT, Williams PP, et al. Depression and anxiety among pregnant women living with HIV in Kilimanjaro region, Tanzania. PLoS ONE. 2019;14(10):e0224515. https:\/\/doi.org\/10.1371\/journal.pone.0224515.","key":"5341_CR22","DOI":"10.1371\/journal.pone.0224515"},{"key":"5341_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12888-019-2321-2","volume":"19","author":"QY Zhu","year":"2019","unstructured":"Zhu QY, Huang DS, Da Lv J, Guan P, Bai X. Prevalence of perinatal depression among HIV-positive women: a systematic review and meta-analysis. BMC Psychiatry. 2019;19:330.","journal-title":"BMC Psychiatry"},{"key":"5341_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.4088\/JCP.14r09186","volume":"76","author":"NA Sowa","year":"2015","unstructured":"Sowa NA, Cholera R, Pence BW, Gaynes BN. Perinatal depression in HIV-infected african women: A systematic review. J Clin Psychiatry. 2015;76:1385\u201396.","journal-title":"J Clin Psychiatry"},{"doi-asserted-by":"publisher","unstructured":"Jean-Louis G, Weber KM, Aouizerat BE, Levine AM, Maki PM, Liu C, et al. Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study. Sleep. 2012;35(1):131\u2013137. Published 2012 Jan 1. doi:https:\/\/doi.org\/10.5665\/sleep.1602","key":"5341_CR25","DOI":"10.5665\/sleep.1602"},{"doi-asserted-by":"publisher","unstructured":"Kunisaki KM, De Francesco D, Sabin CA, Winston A, Mallon PWG, Anderson J, et al. Sleep disorders in human immunodeficiency virus: A Substudy of the pharmacokinetics and clinical observations in people over fifty (POPPY) Study. Open Forum Infect Dis. 2020; 8(1): ofaa561. Published 2020 Nov 18. doi:https:\/\/doi.org\/10.1093\/ofid\/ofaa561","key":"5341_CR26","DOI":"10.1093\/ofid\/ofaa561"},{"key":"5341_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jad.2016.11.020","volume":"209","author":"B Gelaye","year":"2017","unstructured":"Gelaye B, Addae G, Neway B, Larrabure-Torrealva GT, Qiu C, Stoner L, et al. Poor sleep quality, antepartum depression, and suicidal ideation among pregnant women. J Affect Disord. 2017;209:195\u2013200.","journal-title":"J Affect Disord"},{"issue":"4","key":"5341_CR28","first-page":"137","volume":"19","author":"S Letendre","year":"2011","unstructured":"Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011;19(4):137\u201342 PMID: 22156215. PMCID: PMC4666587.","journal-title":"Top Antivir Med"},{"issue":"7","key":"5341_CR29","doi-asserted-by":"publisher","first-page":"922","DOI":"10.4254\/wjh.v7.i7.922.PMID:25954475;PMCID:PMC4419096","volume":"7","author":"A Solinas","year":"2015","unstructured":"Solinas A, Piras MR, Deplano A. Cognitive dysfunction and Hepatitis C virus infection. World J Hepatol. 2015;7(7):922\u20135. https:\/\/doi.org\/10.4254\/wjh.v7.i7.922.PMID:25954475;PMCID:PMC4419096.","journal-title":"World J Hepatol"},{"key":"5341_CR30","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3389\/fpsyg.2018.02666","volume":"9","author":"DP Barreira","year":"2019","unstructured":"Barreira DP, Marinho RT, Bicho M, Fialho R, Ouakinin SRS. Psychosocial and neurocognitive factors associated with Hepatitis C - Implications for future health and wellbeing. Front Psychol. 2019;9:2666. https:\/\/doi.org\/10.3389\/fpsyg.2018.02666.","journal-title":"Front Psychol"},{"key":"5341_CR31","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","volume":"74","author":"R Nemni","year":"2003","unstructured":"Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry. 2003;74:1267\u20132127.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"5341_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/infdis\/jiu429","volume":"211","author":"KE Dooley","year":"2015","unstructured":"Dooley KE, Denti P, Martinson N, Cohn S, Mashabela F, Hoffmann J, et al. Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection. J Infect Dis. 2015;211(2):197\u2013205.","journal-title":"J Infect Dis"},{"doi-asserted-by":"publisher","unstructured":"Manyando C, Njunju EM, D\u2019Alessandro U, Geertruyden JPV. Safety and efficacy of co-trimoxazole for treatment and prevention of plasmodium falciparum malaria: A systematic review. PLoS ONE. 2013;8(2):e56916. doi: https:\/\/doi.org\/10.1371\/journal.pone.0056916. Epub 2013 Feb 22.","key":"5341_CR33","DOI":"10.1371\/journal.pone.0056916"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05341-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05341-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05341-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T09:04:39Z","timestamp":1673946279000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05341-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5341"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05341-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"type":"electronic","value":"1471-2393"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects and from legal guardians of the minors. All experimental protocols were approved by the Institutional Review Boards in all countries and was conducted under Good Clinical Practice per the Helsinki Declaration. The study was approved by several Institutional Review Boards from different countries, and these are listed in Table . South Africa: University of Witwatersrand Research Ethics Committee and South African Health Products Regulation. Botswana: Health Research and Development Committee, Harvard T.H. Chan School of Public Health Office of Regulatory Affairs and Research Compliance and Botswana Drug Regulatory Unit. India: Ethics Committee- B J Medical College and Sassoon General Hospitals. Tanzania: National Institute of Medical Research\u00a0(NIMR). Thailand: The Human Experimentation Committee, Research Institute for Health Sciences, Chiang Mai University and Research Ethics Committee, Faculty of Medicine, Chiang Mai University. Zimbabwe: Medical Research council of Zimbabwe, Medicine Control Authority of Zimbabwe, Research Council of Zimbabwe and Joint Research Ethics Committee for the University of Zimbabwe College of Health Sciences and Parirenyatwa Group of Hospitals.The study only recruited subjects with capacity to give informed consent. During follow up, whilst some of the subjects developed some neurocognitive symptoms, none was serious enough to make diagnosis for neurocognitive disorder, hence informed consent from LARS was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial disclosures to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}